The 25 references in paper S. Nagaytseva S., M. Shvetsov Yu., Yu. Shalyagin D., N. Pyagay L., E. Ivanova S., E. Shilov M., С. Нагайцева С., М. Швецов Ю., Ю. Шалягин Д., Н. Пягай Л., Е. Иванова С., Е. Шилов М. (2013) “ФАКТОРЫ РИСКА ПОВЫШЕНИЯ АЛЬБУМИНУРИИ КАК РАННЕГО МАРКЕРА ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК В РАЗНЫХ ВОЗРАСТНЫХ ГРУППАХ // ASSESSMENT OF ALBUMINURIA AND CHRONIC KIDNEY DISEASE RISK FACTORS IN DIFFERENT GENDER GROUPS” / spz:neicon:nefr:y:2013:i:4:p:58-62

1
Смирнов АВ, Добронравов ВА, Каюков ИГ и др. Эпидемиология и социально-экономические аспекты хронической болезни почек. Нефрология 2006; 10(1):7-13
(check this in PDF content)
2
Бикбов БТ, Томилина НА. Состояние заместительной терапии больных с хронической почечной недостаточностью в Российской Федерации в 1998–2007 гг. (Аналитический отчет по данным Российского регистра заместительной почечной терапии). Нефрология и диализ 2009; 11(3): 144-233
(check this in PDF content)
3
Xue JL, Ma JZ, Louis TA, Collins AJ. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol 2001; 12:2753-2758
(check this in PDF content)
4
Добронравов ВА, Смирнов АВ, Драгунов СВ и др. Эпидемиология хронической болезни почек в Вологодской области. Нефрология 2004; 8(1): 36-41
(check this in PDF content)
5
Coresh J, Selvin E, Stevens L, Manzi J at al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298(17): 2038-2047
(check this in PDF content)
6
ZhangQ-L, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: Systematic review. BMC Public Health 2008; 8:117-124
(check this in PDF content)
7
Добронравов ВА, Смирнов АВ, Каюков ИГ и др. Многогранная альбуминурия: аспекты клинического значения. Нефрология 2009; 13(3):33-38
(check this in PDF content)
8
Швецов МЮ, Бобкова ИН, Колина ИБ, Камышова ЕС. Современные принципы диагностики и лечения хронической болезни почек: методическое руководство для врачей. Шилов ЕМ, ред. Саратов, 2011
(check this in PDF content)
9
Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int 2005;68:228-236
(check this in PDF content)
10
Muntner P, He J, Hamm L. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am SocNephrol 2002; 13:745-753
(check this in PDF content)
11
Yuyun M, Adler A, Wareham N. What is the evidence that microalbuminuria is a predictor of cardiovascular disease events? Curr Opin Nephrol Hypertens 2005;14:271-276
(check this in PDF content)
12
Locatelli F, Vecchio LD, Pozzoni P. The importance of early detection of chronic kidney disease. Nephrol Dial Transplant 2002, 17(11):2-7
(check this in PDF content)
13
Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985; 33: 278-285
(check this in PDF content)
14
Eriksen B, Ingebretsen O. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 2006; 69: 375-382
(check this in PDF content)
15
Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006 3;144(1):21-28
(check this in PDF content)
16
Verhave JC, Hillege HZ, Burgerhof GM et al. The association between atherosclerotic risk factors and renal function in the general population. Kidney Int. 2005; 67: 1967-1973
(check this in PDF content)
17
Мухин НА, Моисеев ВС, Кобалава ЖД и др. Кардиоренальные взаимодействия: клиническое значение и роль в патогенезе заболеваний сердечно-сосудистой системы и почек. Тер арх2004; 6: 39-46
(check this in PDF content)
18
Schiepati A, Remuzzi G. Chronic renal disease as a public health problem: Epidemiology, social and economic implications. Kidney Int 2005; 68 (98): 7-10
(check this in PDF content)
19
Zeeuw D, Hillege HL, de Jong PE. The kidney, a cardiovascular risk marker, and a new target for therapy. Kidney Int Suppl 2005; 98: 25-29
(check this in PDF content)
20
Pinto-Siersma SJ, Mulder J, Janssen WM et al. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med2000; 133: 585-591
(check this in PDF content)
21
Warmoth L, Regalado MM, Simoni J et al. Cigarette smoking enhances increased urine albumin excretion as a risk factor for glomerular filtration rate decline in primary hypertension. Am J Med Sci 2005; 330(3): 111-119
(check this in PDF content)
22
Orth SR. Smoking and the kidney. J Am Soc Nephrol 2002; 13: 1663-1672
(check this in PDF content)
23
Haroun NK, Jaar BG, Hoffman SC et al. Risk factors for chronic Kidney disease: a prospective study of 23.534 men and women in Washington Country, Maryland. J Am Soc Nephrol 2003; 14: 2934-2941
(check this in PDF content)
24
Atkins RC. The epidemiology of chronic kidney disease. Kidney Int 2005; 67 (94): 14-18
(check this in PDF content)
25
Смирнов АВ, Добронравов ВА, Каюков ИГ и др. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. Национальные рекомендации. Нефрология 2012; 16(1): 89115
(check this in PDF content)